Back to search

Article

Insights into the Mechanism of Ethionamide Resistance in <em>Mycobacterium tuberculosis</em> through an <em>in silico</em> Structural Evaluation of EthA and Mutants Identified in Clinical Isolates

2020-03-31

Abstract excerpt

Mutation in the ethionamide (ETH) activating enzyme, EthA, is the main factor determining resistance to this drug, used to treat TB patients infected with MDR and XDR Mycobacterium tuberculosis isolates. Many mutations in EthA of ETH resistant (ETH-R) isolates have been described but their roles in resistance remain uncharacterized, partly because structural studies on the enzyme are lacking. Thus, we took a two-t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cb5aef71-1823-543f-90f5-6e2e44d015cc
DOI
10.20944/preprints202003.0470.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Insights into the Mechanism of Ethionamide Resistance in <em>Mycobacterium tuberculosis</em> through an <em>in silico</em> Structural Evaluation of EthA and Mutants Identified in Clinical IsolatesDOI 10.20944/preprints202003.0470.v1
Select a neighboring publication to make it the new centre.